John S. Abrams, PhD. has over 40 years of experience in biotech, including several decades of senior executive science leadership (with over 20 years at DNAX Research Institute / Schering-Plough). He received his undergraduate degree in Biochemistry from UC Berkeley and awarded a Ph.D in Biochemistry from McGill University. He has authored over 100 scientific publications and patents and is experienced with early research program design and implementation as well as preclinical and clinical development. More recently, he served as the 2019 Scientific Director of the Emerald Conference where he also presented on some of the science behind chemotyping.